The clinical utility of faecal calprotectin in patients with differentiated and undifferentiated spondyloarthritis: Relevance and clinical implications Yasser Emad, Yasser Ragab, Nevin Hammam, Nashwa El-Shaarawy, Magdy Fawzi, Arwa Amer, Hesham El-Makhzangy, Ahmed Ismail, Ossama Ibrahim, Yosra Hassan, Ahmed Kamal, Johannes J. Rasker

Do patients with axial spondyloarthritis with active disease suffer from greater disease burden and work impairment? Results from the International Map of Axial Spondyloarthritis (IMAS) Marco Garrido-Cumbrera, Denis Poddubnyy, Fernando Sommerfleck, Christine Bundy, Souzi Makri, José Correa-Fernández, Shashank Akerkar, Jo Lowe, Elie Karam, Victoria Navarro-Compán

Association between serum dickkopf-1 levels and disease duration in axial spondyloarthritis Roxana Rubio Vargas, Enrique Melguizo Madrid, Concepción González Rodríguez, Federico Navarro Sarabia, Carmen Dominguez Quesada, Rafael Ariza Ariza, Victoria Navarro Compán